Amarin Corp. Plc (AMRN)
14.49
-0.29
(-1.96%)
USD |
NASDAQ |
May 15, 16:00
14.50
+0.01
(+0.07%)
After-Hours: 20:00
Amarin EPS Diluted (Quarterly) : -0.501 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | 1.023 |
| Alkermes Plc | -0.40 |
| Catalyst Pharmaceuticals, Inc. | 0.5022 |
| Biodexa Pharmaceuticals Plc | -- |
| Trinity Biotech Plc | -0.9375 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -10.49M |
| Revenue (Quarterly) | 45.06M |
| Total Expenses (Quarterly) | 55.55M |
| Enterprise Value | 1.404M |
| Gross Profit Margin (Quarterly) | 37.96% |
| Profit Margin (Quarterly) | -23.29% |
| Earnings Yield | -11.18% |
| Normalized Earnings Yield | -1.932 |